SOCS2 is hypermethylated in ovarian and breast cancers, in which its reduced expression is associated with the activation of STAT3, indicating an increased cytokine responsiveness in these tumors (Sutherland et al. 2004). This evidence concerns the gene STAT3 and breast cancer.